Literature DB >> 21557738

The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v) 1.2 channels.

S Saponara1, E Carosati, P Mugnai, G Sgaragli, F Fusi.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies have pointed to the plant flavonoids myricetin and quercetin as two structurally related stimulators of vascular Ca(v) 1.2 channel current (I(Ca1.2) ). Here we have tested the proposition that the flavonoid structure confers the ability to modulate Ca(v) 1.2 channels. EXPERIMENTAL APPROACH: Twenty-four flavonoids were analysed for their effects on I(Ca1.2) in rat tail artery myocytes, using the whole-cell patch-clamp method. KEY
RESULTS: Most of the flavonoids stimulated or inhibited I(Ca1.2) in a concentration- and voltage-dependent manner with EC(50) values ranging between 4.4 µM (kaempferol) and 16.0 µM (myricetin) for the stimulators and IC(50) values between 13.4 µM (galangin) and 100 µM [(±)-naringenin] for the inhibitors. Key structural requirements for I(Ca1.2) stimulatory activity were the double bond between C2 and C3 and the hydroxylation pattern on the flavonoid scaffold, the latter also determining the molecular charge, as shown by molecular modelling techniques. Absence of OH groups in the B ring was key in I(Ca1.2) inhibition. The functional interaction between quercetin and either the stimulator myricetin or the antagonists resokaempferol, crysin, genistein, and 5,7,2'-trihydroxyflavone revealed that quercetin expressed the highest apparent affinity, in the low µM range, for Ca(v) 1.2 channels. Neither protein tyrosine kinase nor protein kinase Cα were involved in quercetin-induced stimulation of I(Ca1.2). CONCLUSIONS AND IMPLICATIONS: Quercetin-like plant flavonoids were active on vascular Ca(v)1.2 channels. Thus, the flavonoid scaffold may be a template for the design of novel modulators of vascular smooth muscle Ca(v)1.2 channels, valuable for the treatment of hypertension and stroke.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557738      PMCID: PMC3230815          DOI: 10.1111/j.1476-5381.2011.01476.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.

Authors:  S Wijetunge; J S Lymn; A D Hughes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638.

Authors:  S V Smirnov; P I Aaronson
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery.

Authors:  G V Petkov; F Fusi; S Saponara; H S Gagov; G P Sgaragli; K K Boev
Journal:  Acta Physiol Scand       Date:  2001-11

Review 5.  Flavonols and cardiovascular disease.

Authors:  Francisco Perez-Vizcaino; Juan Duarte
Journal:  Mol Aspects Med       Date:  2010-09-15

6.  2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca(2+) channel via superoxide anion generation.

Authors:  F Fusi; S Saponara; H Gagov; G Sgaragli
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Quercetin as a novel activator of L-type Ca(2+) channels in rat tail artery smooth muscle cells.

Authors:  Simona Saponara; Giampietro Sgaragli; Fabio Fusi
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

8.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

9.  L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles.

Authors:  Fabio Fusi; Simona Saponara; Maria Frosini; Beatrice Gorelli; Giampietro Sgaragli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-15       Impact factor: 3.000

10.  Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src.

Authors:  H Glossmann; P Presek; E Eigenbrodt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

View more
  16 in total

1.  Pharmacological potential of Populus nigra extract as antioxidant, anti-inflammatory, cardiovascular and hepatoprotective agent.

Authors:  Nadjet Debbache-Benaida; Dina Atmani-Kilani; Valérie Barbara Schini-Keirth; Nouredine Djebbli; Djebbar Atmani
Journal:  Asian Pac J Trop Biomed       Date:  2013-09

2.  Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.

Authors:  Reddemma Sandireddy; Veera Ganesh Yerra; Prashanth Komirishetti; Aparna Areti; Ashutosh Kumar
Journal:  Cell Mol Neurobiol       Date:  2015-09-23       Impact factor: 5.046

3.  Inhibition of transmembrane member 16A calcium-activated chloride channels by natural flavonoids contributes to flavonoid anticancer effects.

Authors:  Xuan Zhang; Honglin Li; Huiran Zhang; Yani Liu; Lifang Huo; Zhanfeng Jia; Yucong Xue; Xiaorun Sun; Wei Zhang
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

4.  Mouse sperm membrane potential hyperpolarization is necessary and sufficient to prepare sperm for the acrosome reaction.

Authors:  Jose Luis De La Vega-Beltran; Claudia Sánchez-Cárdenas; Darío Krapf; Enrique O Hernandez-González; Eva Wertheimer; Claudia L Treviño; Pablo E Visconti; Alberto Darszon
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

5.  The ellagitannin metabolite urolithin C is a glucose-dependent regulator of insulin secretion through activation of L-type calcium channels.

Authors:  Morgane Bayle; Jérémie Neasta; Margherita Dall'Asta; Guillaume Gautheron; Anne Virsolvy; Jean-François Quignard; Estelle Youl; Richard Magous; Jean-François Guichou; Alan Crozier; Daniele Del Rio; Gérard Cros; Catherine Oiry
Journal:  Br J Pharmacol       Date:  2019-10-10       Impact factor: 8.739

6.  Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells.

Authors:  G Bardy; A Virsolvy; J F Quignard; M A Ravier; G Bertrand; S Dalle; G Cros; R Magous; S Richard; C Oiry
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Various In Vitro Bioactivities of Secondary Metabolites Isolated from the Sponge Hyrtios aff. Erectus from the Red Sea Coast of Egypt.

Authors:  Asmaa Nabil-Adam; Mohamed A Shreadah; Nehad M Abd El Moneam; Samy A El-Assar
Journal:  Turk J Pharm Sci       Date:  2020-04-24

8.  From in silico to in vitro: a trip to reveal flavonoid binding on the Rattus norvegicus Kir6.1 ATP-sensitive inward rectifier potassium channel.

Authors:  Alfonso Trezza; Vittoria Cicaloni; Piera Porciatti; Andrea Langella; Fabio Fusi; Simona Saponara; Ottavia Spiga
Journal:  PeerJ       Date:  2018-05-02       Impact factor: 2.984

9.  Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia.

Authors:  Chuanhong Wu; Jianxin Chen; Chang Chen; Wei Wang; Limei Wen; Kuo Gao; Xiuping Chen; Sihuai Xiong; Huihui Zhao; Shaojing Li
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

10.  Natural and synthetic flavonoid modulation of TRPC5 channels.

Authors:  Jacqueline Naylor; Aisling Minard; Hannah J Gaunt; Mohamed S Amer; Lesley A Wilson; Marco Migliore; Sin Y Cheung; Hussein N Rubaiy; Nicola M Blythe; Katie E Musialowski; Melanie J Ludlow; William D Evans; Ben L Green; Hongjun Yang; Yun You; Jing Li; Colin W G Fishwick; Katsuhiko Muraki; David J Beech; Robin S Bon
Journal:  Br J Pharmacol       Date:  2016-01-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.